Utah Medical Products, Inc.
UTMD
$71.10
$0.390.55%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 10.49M | 10.85M | 11.29M | 11.62M | 12.55M |
| Total Depreciation and Amortization | 2.46M | 2.98M | 3.01M | 2.98M | 2.95M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 282.00K | 175.00K | 81.00K | 149.00K | -66.00K |
| Change in Net Operating Assets | -1.38M | -662.00K | 317.00K | -597.00K | -1.31M |
| Cash from Operations | 11.85M | 13.34M | 14.69M | 14.15M | 14.13M |
| Capital Expenditure | -400.00K | -317.00K | -371.00K | -271.00K | -333.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 0.00 | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 0.00 | 0.00 |
| Cash from Investing | -400.00K | -317.00K | -371.00K | -271.00K | -333.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | 0.00 | 0.00 |
| Repurchase of Common Stock | -1.85M | -5.26M | -8.36M | -14.07M | -17.28M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -3.94M | -3.96M | -3.98M | -4.04M | -4.11M |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -5.79M | -9.22M | -12.34M | -18.11M | -21.39M |
| Foreign Exchange rate Adjustments | -304.00K | 278.00K | 797.00K | 48.00K | 554.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5.35M | 4.08M | 2.78M | -4.19M | -7.04M |